Viveve Medical(VIVE)
$0.000.00 (0.00%)
VIVE
Viveve Medical financials statements
$0.00
At close:0.00 (0.00%)
Viveve Medical (VIVE) Ratios
513 Followers
Viveve Medical Ratios
VIVE's free cash flow for Q3 2022 was $-3.54M. For the 2022 fiscal year, VIVE's free cash flow was decreased by $-193.00K and operating cash flow was $-3.35M. See a summary of the company’s cash flow.
| Ratios | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.91 | 3.05 | 3.52 | 3.89 | 3.41 |
| Quick Ratio | 4.58 | 2.27 | 2.75 | 3.51 | 3.16 |
| Cash Ratio | 4.23 | 1.55 | 2.11 | 2.74 | 2.20 |
| Solvency Ratio | -1.93 | -2.14 | -3.95 | -1.15 | -0.94 |
| Operating Cash Flow Ratio | -2.84 | -3.61 | -4.95 | -4.00 | -3.71 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -16.59 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 11.39M | $ 3.19M | $ 11.73M | $ -18.00K | $ -6.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.36 | 0.16 | 0.65 | 0.80 |
| Debt-to-Equity Ratio | 0.36 | 0.86 | 0.26 | 6.21 | -11.13 |
| Debt-to-Capital Ratio | 0.26 | 0.46 | 0.20 | 0.86 | 1.10 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.41 | 0.19 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.72 | 2.38 | 1.63 | 9.53 | -13.88 |
| Debt Service Coverage Ratio | -19.89 | -10.78 | -8.15 | -10.07 | -10.42 |
| Interest Coverage Ratio | -21.55 | -20.32 | -6.88 | -10.28 | -10.64 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.63 | 4.39 | 22.45 | 1123.67 | 1835.68 |
| Net Debt to EBITDA | 0.70 | 0.03 | 0.30 | -0.02 | -0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.65% | 5.40% | 15.47% | 39.53% | 48.69% |
| EBIT Margin | -323.23% | -376.38% | -571.72% | -242.76% | -221.02% |
| EBITDA Margin | -305.51% | -352.71% | -467.17% | -238.52% | -218.09% |
| Operating Profit Margin | -335.40% | -337.56% | -455.87% | -242.83% | -220.63% |
| Pretax Profit Margin | -338.80% | -392.99% | -638.02% | -266.37% | -241.75% |
| Net Profit Margin | -342.78% | -399.98% | -647.57% | -265.60% | -239.60% |
| Continuous Operations Profit Margin | -342.78% | -399.98% | -647.57% | -269.92% | -241.75% |
| Net Income Per EBT | 101.18% | 101.78% | 101.50% | 99.71% | 99.11% |
| EBT Per EBIT | 101.01% | 116.42% | 139.96% | 109.69% | 109.57% |
| Return on Assets (ROA) | -85.00% | -131.78% | -157.64% | -105.01% | -101.53% |
| Return on Equity (ROE) | -146.20% | -314.24% | -257.41% | -1001.26% | 1408.85% |
| Return on Capital Employed (ROCE) | -100.81% | -148.97% | -144.83% | -124.65% | -126.45% |
| Return on Invested Capital (ROIC) | -99.76% | -137.36% | -142.97% | -124.29% | -125.32% |
| Return on Tangible Assets | -85.00% | -131.78% | -157.64% | -105.01% | -101.53% |
| Earnings Yield | -0.02% | -0.03% | -0.09% | -0.02% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.70 | 7.12 | 4.17 | 3.25 | 2.46 |
| Payables Turnover | 3.92 | 5.88 | 3.45 | 2.80 | 1.63 |
| Inventory Turnover | 3.94 | 1.59 | 1.14 | 2.72 | 3.28 |
| Fixed Asset Turnover | 4.14 | 1.99 | 2.16 | 6.35 | 11.73 |
| Asset Turnover | 0.25 | 0.33 | 0.24 | 0.40 | 0.42 |
| Working Capital Turnover Ratio | 0.49 | 0.45 | 0.28 | 0.69 | 1.04 |
| Cash Conversion Cycle | 30.68 | 218.41 | 301.33 | 116.51 | 36.24 |
| Days of Sales Outstanding | 31.18 | 51.30 | 87.43 | 112.44 | 148.33 |
| Days of Inventory Outstanding | 92.54 | 229.15 | 319.63 | 134.27 | 111.21 |
| Days of Payables Outstanding | 93.04 | 62.04 | 105.73 | 130.20 | 223.31 |
| Operating Cycle | 123.72 | 280.45 | 407.06 | 246.71 | 259.55 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.28 | -9.68 | -81.51 | -1387.36 | -1992.06 |
| Free Cash Flow Per Share | -1.32 | -10.18 | -84.34 | -1456.33 | -2043.78 |
| Dividend Paid and CapEx Coverage Ratio | -28.24 | -19.51 | -21.32 | -20.12 | -38.51 |
| Capital Expenditure Coverage Ratio | -28.24 | -19.51 | -28.74 | -20.12 | -38.51 |
| Operating Cash Flow Coverage Ratio | -2.41 | -2.54 | -7.35 | -1.41 | -1.20 |
| Operating Cash Flow to Sales Ratio | -2.00 | -2.78 | -4.76 | -2.33 | -2.28 |
| Free Cash Flow Yield | -0.01% | -0.02% | -0.07% | -0.01% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5221.90 | -3374.67 | -1135.48 | -6630.87 | -23738.77 |
| Price-to-Sales (P/S) Ratio | 17899.60 | 13498.05 | 7353.03 | 17611.90 | 56878.02 |
| Price-to-Book (P/B) Ratio | 7634.60 | 10604.50 | 2922.79 | 66392.41 | -334442.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8626.28 | -4617.91 | -1493.90 | -7209.93 | -24317.67 |
| Price-to-Operating Cash Flow Ratio | -8931.73 | -4854.66 | -1545.89 | -7568.33 | -24949.11 |
| Price-to-Earnings Growth (PEG) Ratio | 62.17 | 39.05 | 12.30 | 272.14 | 5940.85 |
| Enterprise Value Multiple | -5858.24 | -3826.92 | -1573.66 | -7383.97 | -26080.78 |
| Enterprise Value | 115.01B | 73.96B | 48.28B | 326.12B | 869.56B |
| EV to EBITDA | -5858.24 | -3826.92 | -1573.66 | -7383.97 | -26080.78 |
| EV to Sales | 17897.45 | 13497.95 | 7351.65 | 17611.95 | 56878.56 |
| EV to Free Cash Flow | -8625.25 | -4617.88 | -1493.62 | -7209.95 | -24317.90 |
| EV to Operating Cash Flow | -8930.66 | -4854.62 | -1545.60 | -7568.36 | -24949.34 |
| Tangible Book Value Per Share | 1.49 | 4.43 | 43.11 | 158.15 | -148.61 |
| Shareholders’ Equity Per Share | 1.49 | 4.43 | 43.11 | 158.15 | -148.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.02 | -0.12 | 0.00 | 0.01 |
| Revenue Per Share | 0.64 | 3.48 | 17.14 | 596.19 | 873.80 |
| Net Income Per Share | -2.18 | -13.93 | -110.97 | -1583.50 | -2093.62 |
| Tax Burden | 1.01 | 1.02 | 1.01 | 1.00 | 0.99 |
| Interest Burden | 1.05 | 1.04 | 1.12 | 1.10 | 1.09 |
| Research & Development to Revenue | 1.50 | 0.94 | 1.31 | 0.74 | 0.81 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.59 | 0.48 | 0.37 | 0.16 | 0.12 |
| Income Quality | 0.58 | 0.70 | 0.73 | 0.86 | 0.94 |
Currency in USD
